Evidence map›Paper›PMID 38872021›Full record

ArticleSurgical endoscopy2024

Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomes.

Kamal Abi Mosleh, Jack W Sample, Amanda Belluzzi, Katarzyna Bartosiak, Davekaran Buttar, Richard S Betancourt, Aleksandra Kukla, Tayyab S Diwan, Omar M Ghanem

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kamal Abi MoslehDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Jack W SampleDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Amanda BelluzziDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Katarzyna BartosiakDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Davekaran ButtarDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Richard S BetancourtMayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.
Aleksandra KuklaDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Tayyab S DiwanDepartment of Transplantation Surgery, Von Liebig Transplant Center, Mayo Clinic, Rochester, MN, USA.
Omar M GhanemDepartment of Surgery, Mayo Clinic, Rochester, MN, USA. Ghanem.omar@mayo.edu.ORCID 0000-0002-5725-8497

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity and its related medical conditions are well-established contributors to the development of chronic kidney disease (CKD). Metabolic and bariatric surgery (MBS), including procedures such as sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), is a potential intervention for these individuals. However, the heightened risk of postoperative complications casts doubts on the suitability of MBS in this population. Our aim is to evaluate the long-term safety, anthropometric and renal outcomes of MBS in patients with CKD.

methodsA retrospective review of patients who underwent primary laparoscopic MBS with a BMI ≥ 35 kg/m

resultsA total of 302 patients (177 SG, 125 RYGB) were included. RYGB was preferred for patients with stage 3 CKD, while SG was more common in stages 4 and 5. At 5-year follow-up, percentage of total weight loss was higher in the RYGB cohort compared to SG (25.1% vs. 18.6%, p = 0.036). Despite SG patients having more advanced CKD, the incidence of late complications was significantly higher following RYGB, with 11 incidents (8.8%), compared to the SG cohort with only 4 cases (2.3%) (p = 0.014). In those with preoperative CKD stage 3, 76 patients (43.2%) improved to stage 2, with another 9 patients (5.1%) improving further to stage 1. Of all patients, 63 (20.8%) eventually received a successful renal transplant.

conclusionsMBS is an effective strategy for sustained weight loss in patients with CKD with acceptable complications rates. RYGB leads to a higher percentage of overall weight loss, albeit with an elevated likelihood of late surgical complications. Future studies are needed to determine the safety of MBS in this demographic.

Indexed as

Bariatric SurgeryPostoperative ComplicationsRenal Insufficiency, ChronicAdultFemaleFollow-Up StudiesGastrectomyGastric BypassGlomerular Filtration RateHumansLaparoscopyMaleMiddle AgedObesity, MorbidRetrospective StudiesTreatment OutcomeChronic kidney diseaseMetabolic and bariatric surgeryRenal transplantationRoux-en-Y gastric bypassSleeve gastrectomyWeight loss

Identifiers

PMID38872021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.